Suppr超能文献

[正常血压受试者中具有利钠和钠钾ATP酶抑制特性的血浆的存在及调节]

[Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].

作者信息

Krzesinski J M, Potier J P, Godon J P, Rorive G L

机构信息

Service de Néphrologie, CHU Sart Tilman, Université de Liège, Belgique.

出版信息

Arch Mal Coeur Vaiss. 1987 Jun;80(6):960-5.

PMID:2821949
Abstract

In hypertension, mainly low renin subjects, a plasma Na-K ATPase inhibitor has yet been demonstrated. Moreover, it has been established that the concentration of this activity may be modulated by variations of the sodium and water balance. In the present study, such an activity and its role has been searched in the plasma of young healthy normotensive population. Its potential natriuretic property has also been tested. Twenty male subjects, younger than 30, volunteered 3 very different sodium diets: normal (+/- 170 mM/d), very low (-20 mM/d) and very high sodium intake (+340 mM/d). At the end of each period, some clinical and biological parameters have been studied: blood pressure, weight, vascular resistances and reactivity to norepinephrine, 24 h natriuresis, and plasma renin activity. Furthermore, the plasma natriuretic activity has been tested after filtration of the plasma across different Amicon filters to measure the effect of plasma extracts from 500 to 10,000 daltons (LMW) on fractional sodium excretion (FENa) after injection of such extracts in vivo in rat renal artery. For detection of a plasma Na-K ATPase inhibitor activity, 1/5 th diluted fresh plasma and LMW extracts have been incubated with purified rabbit renal Na-K ATPase enzyme and compared with the activity of this enzyme without such an incubation of plasma. We have observed that when the amount of sodium in the diet is higher, weight, systolic blood pressure, and vascular reactivity to norepinephrine increase. In the same condition, there are greater natriuretic activity in the LMW extracts and Na-K ATPase inhibitor activity in fresh plasma and LMW extracts of the normotensive people.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在高血压患者中,主要是低肾素患者,血浆钠钾ATP酶抑制剂尚未得到证实。此外,已经确定这种活性的浓度可能会受到钠和水平衡变化的调节。在本研究中,在年轻健康的血压正常人群的血浆中寻找了这种活性及其作用。还测试了其潜在的利钠特性。20名年龄小于30岁的男性受试者自愿采用3种截然不同的钠饮食:正常饮食(±170 mM/d)、极低钠饮食(-20 mM/d)和极高钠饮食(+340 mM/d)。在每个阶段结束时,研究了一些临床和生物学参数:血压、体重、血管阻力和对去甲肾上腺素的反应性、24小时尿钠排泄以及血浆肾素活性。此外,在血浆通过不同的Amicon滤器过滤后,测试了血浆利钠活性,以测量500至10000道尔顿(低分子量)的血浆提取物在大鼠肾动脉内注射后对钠排泄分数(FENa)的影响。为了检测血浆钠钾ATP酶抑制剂活性,将1/5稀释的新鲜血浆和低分子量提取物与纯化的兔肾钠钾ATP酶一起孵育,并与未进行血浆孵育的该酶活性进行比较。我们观察到,当饮食中的钠含量较高时,体重、收缩压和对去甲肾上腺素的血管反应性会增加。在相同条件下,血压正常者的低分子量提取物中的利钠活性以及新鲜血浆和低分子量提取物中的钠钾ATP酶抑制剂活性更高。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验